<p><strong>奥驰亚集团（Altria Group Inc.）</strong>（<strong>纽约证券交易所代码：MO</strong>）在过去一个月的表现优于大盘，涨幅达到 1.60%，而标准普尔 500 指数在同一时期下跌了-8.60%。这一表现使得该股年初至今的涨幅达到了 11.54%，同时支付了丰厚的股息，目前的股息收益率为 6.97%。截至 2025 年，作为股息之王，奥驰亚不仅超越了其基准指数，还继续回馈收入投资者，过去 55 年中已增加了 59 次分红。</p>
<p>尽管如此高的派息比率并未妨碍股价上涨，该股在过去六个月内上涨了 17%，在过去一年内上涨了 37.59%，在同一时期内超越了标准普尔 500 指数，涨幅高达 32.49%。</p>
<p>在标志性的美国品牌中，奥驰亚的万宝路香烟与 iPhone、Levi 牛仔裤和可口可乐一样家喻户晓。虽然公司的起源可以追溯到 1822 年乔治·韦曼的烟草店，但奥驰亚在 1920 年以菲利普·莫里斯（Philip Morris）名义提交了第一份年报，并在 20 世纪及以后主导了美国烟草市场。随着菲利普·莫里斯收购了通用食品和卡夫等公司，2003 年更名为奥驰亚集团，同时保留了 “MO” 股票代码。</p>
<p><img src="https://imageproxy.pbkrs.com/https://247wallst.com/wp-content/uploads/2025/01/Follow-Our-500000-AI-Portfolio-3.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://247wallst.com/wp-content/uploads/2025/01/Follow-Our-500000-AI-Portfolio-3.jpg"/></p>
<p>由于与烟草使用相关的健康风险导致立法限制，奥驰亚的增长速度虽然有所放缓，但作为股息之王和机构投资者的宠儿，该公司仍然在历史上表现可靠，正如 2025 年迄今的表现所示，完全有能力应对严重的市场下跌。</p>
<h2>本文要点：</h2>
<ul>
<li>奥驰亚收购电子烟制造商 NJOY，使其获得了庞大的分销网络。</li>
<li>万宝路在美国香烟行业中仍占据 42% 的市场份额。</li>
<li>如果你在寻找具有巨大潜力的重大趋势，确保获取我们免费的《下一个 NVIDIA》报告。该报告详细分析了具有 10 倍潜力的人工智能股票，将为你在这一重大变革中获利提供巨大的帮助。</li>
</ul>
<h2>奥驰亚近期股票成功</h2>
<p>2016 年，奥驰亚收购了 <strong>安海斯 - 布希英博（Anheuser Busch InBev NV ADR）</strong>（<strong>纽约证券交易所代码：BUD</strong>）10% 的股份，该公司是百威啤酒的制造商。此后，该公司将其持股比例减少至 8%，但最初的投资标志着一系列并购活动，增加了资本支出，同时内在地提高了公司的估值。2018 年收购了谢尔曼集团控股公司（Sherman Group Holdings, LLC），随后在 2019 年将海利克斯创新公司（Helix Innovations）和克罗诺斯集团（Cronos Group）——一家医疗和娱乐大麻公司——纳入奥驰亚的投资组合。2023 年，该公司收购了 NJOY。</p>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>财年</strong></td>
<td><strong>价格</strong></td>
<td><strong>收入</strong></td>
<td><strong>净收入</strong></td>
</tr>
<tr>
<td>2015</td>
<td>$58.21</td>
<td>$188.54 亿</td>
<td>$52.41 亿</td>
</tr>
<tr>
<td>2016</td>
<td>$67.62</td>
<td>$193.37 亿</td>
<td>$142.39 亿</td>
</tr>
<tr>
<td>2017</td>
<td>$71.41</td>
<td>$194.94 亿</td>
<td>$102.22 亿</td>
</tr>
<tr>
<td>2018</td>
<td>$49.39</td>
<td>$196.27 亿</td>
<td>$69.63 亿</td>
</tr>
<tr>
<td>2019</td>
<td>$49.91</td>
<td>$197.96 亿</td>
<td>(-$12.39 亿)</td>
</tr>
<tr>
<td>2020</td>
<td>$41.00</td>
<td>$208.41 亿</td>
<td>$44.67 亿</td>
</tr>
<tr>
<td>2021</td>
<td>$47.39</td>
<td>$211.11 亿</td>
<td>$24.75 亿</td>
</tr>
<tr>
<td>2022</td>
<td>$45.71</td>
<td>$206.88 亿</td>
<td>$57.64 亿</td>
</tr>
<tr>
<td>2023</td>
<td>$40.34</td>
<td>$205.02 亿</td>
<td>$81.30 亿</td>
</tr>
<tr>
<td>2024</td>
<td>$52.38</td>
<td>$240.18 亿</td>
<td>$112.36 亿</td>
</tr>
</tbody>
</table>
<p>从 2020 财年到 2024 财年，奥驰亚以股息的形式向股东返还了超过 320 亿美元。在此期间，公司还回购了价值 79 亿美元的股票。从 2023 年 8 月到 2024 年 8 月，该公司将股息提高了超过 4.1%。</p>
<h2>奥驰亚未来股票的关键驱动因素</h2>
<p><strong>1. 对无烟产品的需求增长：</strong> 全球无烟产品行业的价值为 168.1 亿美元，预计在 2024 年至 2030 年期间将以 4.8% 的年复合增长率（CAGR）增长。虽然 84.9% 的分销是线下的，但预计在线分销在 2030 年前将以 6.2% 的 CAGR 增长，这可能会帮助推动销售，因为这些产品继续扩大其全球影响力。NJOY 获得了 FDA 首次批准的薄荷电子蒸汽产品的市场营销许可。</p>
<p><strong>2. 持续的股息增长：</strong> 去年，奥驰亚实现了连续第 55 年的股息增长。该股继续受到收入投资者的青睐，目前的股息收益率为 6.97%。作为对比，收益投资者的热门选择 <strong>施瓦布美国股息股票 ETF（Schwab U.S. Dividend Equity ETF）</strong>（<strong>纽约证券交易所代码：SCHD</strong>）目前仅支付 4.18% 的股息，并且年初至今已下跌-6.97%。因此，奥驰亚继续为投资者提供安全的避风港、诱人的（且可持续的）收益和令人印象深刻的股价表现。</p>
<p><strong>3. 新兴市场：</strong> 克罗诺斯（Cronos，含大麻成分）和海利克斯（Helix，口腔尼古丁袋）均在 2019 年被收购，应该有助于奥驰亚在这些市场的扩展。考虑到 FDA 在 2025 年 1 月宣布已授权 20 种 ZYN 尼古丁袋产品的市场营销——这是一个主要竞争对手——这一点尤其相关，经过广泛的科学审查。</p>
<p><img src="https://imageproxy.pbkrs.com/https://247wallst.com/wp-content/uploads/2019/01/imageforentry15-quc.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://247wallst.com/wp-content/uploads/2019/01/imageforentry15-quc.jpg"/></p>
<h2>奥驰亚（MO）2025 年价格预测</h2>
<p>根据华尔街分析师的观点，奥驰亚集团当前的一年期共识目标价为 54.88 美元，这意味着在未来 12 个月内相较于当前股价有-6.28% 的潜在下跌。在覆盖 MO 的九位分析师中，该股被给予共识 “持有” 评级，其中三位给予 “买入” 评级，四位给予 “持有” 评级，二位给予 “卖出” 评级。</p>
<p>然而，<strong>24/7 Wall Street</strong> 的预测则不那么悲观，预计奥驰亚集团的目标价为 56.65 美元，或-2.20% 的潜在下跌。我们认为，奥驰亚的高股息和相对较低的市盈率将继续吸引投资者，从而在大盘持续下跌的情况下支撑股价。</p>
<h2>奥驰亚股票价格目标 2025–2030</h2>
<p>到 2030 年末，<strong>24/7 Wall Street</strong> 预计奥驰亚集团的股票将交易至 65.15 美元，相较于今天的股价上涨 11.25%，基于每股收益为 6.05 美元。</p>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>年份</strong></td>
<td><strong>每股收益</strong></td>
<td><strong>目标价格</strong></td>
<td><strong>与当前价格的变化百分比</strong></td>
</tr>
<tr>
<td>2025</td>
<td>$5.32</td>
<td>$57.27</td>
<td>-2.20%</td>
</tr>
<tr>
<td>2026</td>
<td>$5.50</td>
<td>$59.24</td>
<td>1.16%</td>
</tr>
<tr>
<td>2027</td>
<td>$5.67</td>
<td>$61.06</td>
<td>4.26%</td>
</tr>
<tr>
<td>2028</td>
<td>$5.77</td>
<td>$62.10</td>
<td>6.04%</td>
</tr>
<tr>
<td>2029</td>
<td>$5.90</td>
<td>$63.55</td>
<td>8.52%</td>
</tr>
<tr>
<td>2030</td>
<td>$6.05</td>
<td>$65.15</td>
<td>11.25%</td>
</tr>
</tbody>
</table>
<p>关于奥驰亚集团（NYSE: MO）的价格预测与 2025-2030 年展望（2025 年 4 月）首次发布于 24/7 Wall St..</p>

奥驰亚集团

<p>奥驰亚集团（Altria Group Inc.，纽约证券交易所代码：MO）在过去一个月中表现优于标准普尔 500 指数，涨幅为 1.60%，年初至今涨幅为 11.54%，同时提供 6.97% 的股息收益率。该公司以万宝路品牌闻名，市场份额强劲，并连续 55 年提高股息。最近的收购，包括 NJOY，使奥驰亚在无烟产品市场中占据了良好的位置，该市场预计将显著增长。该股票表现出韧性，过去一年上涨了 37.59%，成为收入投资者的可靠选择</p>

<p>Shares of <strong>Altria Group Inc. (</strong> <strong>NYSE: MO</strong> <strong>)</strong> have outperformed the broad market over the past month by mustering a gain of 1.60% while the S&amp;P 500 has lost -8.60% over the same period. That performance has helped the stock with a year-to-date gain of 11.54% while also paying a sizable dividend that currently yields 6.97%. So far in 2025, the Dividend King is not only outpacing its benchmark index but continuing to reward income investors as it has now increased its distribution 59 times over the past 55 years.</p>
<div class="lb-trans"><p><strong>奥驰亚集团（Altria Group Inc.）</strong>（<strong>纽约证券交易所代码：MO</strong>）在过去一个月的表现优于大盘，涨幅达到 1.60%，而标准普尔 500 指数在同一时期下跌了-8.60%。这一表现使得该股年初至今的涨幅达到了 11.54%，同时支付了丰厚的股息，目前的股息收益率为 6.97%。截至 2025 年，作为股息之王，奥驰亚不仅超越了其基准指数，还继续回馈收入投资者，过去 55 年中已增加了 59 次分红。</p>
</div><p>That sizable payout ratio hasn’t hindered share appreciation, though, as the stock has gained 17% over the past six months and is up 37.59% over the past year, outperforming the S&amp;P 500 over the same period by an eye-catching 32.49%.</p>
<div class="lb-trans"><p>尽管如此高的派息比率并未妨碍股价上涨，该股在过去六个月内上涨了 17%，在过去一年内上涨了 37.59%，在同一时期内超越了标准普尔 500 指数，涨幅高达 32.49%。</p>
</div><p>Among iconic American brands, Altria’s Marlboro cigarettes are as recognizable as iPhones, Levi Jeans and Coca-Cola. While the company’s origins can be traced back to George Weyman’s tobacco shop in 1822, Altria filed its first annual report as Philip Morris in 1920 and would come to dominate U.S. tobacco throughout the 20th century and beyond. As Philip Morris branched out to acquire General Foods and Kraft, among others, it changed its name in 2003 to Altria Group while retaining the “MO” ticker.</p>
<div class="lb-trans"><p>在标志性的美国品牌中，奥驰亚的万宝路香烟与 iPhone、Levi 牛仔裤和可口可乐一样家喻户晓。虽然公司的起源可以追溯到 1822 年乔治·韦曼的烟草店，但奥驰亚在 1920 年以菲利普·莫里斯（Philip Morris）名义提交了第一份年报，并在 20 世纪及以后主导了美国烟草市场。随着菲利普·莫里斯收购了通用食品和卡夫等公司，2003 年更名为奥驰亚集团，同时保留了 “MO” 股票代码。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://247wallst.com/wp-content/uploads/2025/01/Follow-Our-500000-AI-Portfolio-3.jpg" alt="" original-src="https://247wallst.com/wp-content/uploads/2025/01/Follow-Our-500000-AI-Portfolio-3.jpg"/></p>
<p>Altria has continued to grow at an albeit slower pace, due to health risks associated with tobacco use that has caused legislative restrictions. However, as a Dividend King and an institutional investment favorite, the company remains historically reliable and, as evidenced by its performance so far in 2025, more than capable of weathering severe market downturns.</p>
<div class="lb-trans"><p>由于与烟草使用相关的健康风险导致立法限制，奥驰亚的增长速度虽然有所放缓，但作为股息之王和机构投资者的宠儿，该公司仍然在历史上表现可靠，正如 2025 年迄今的表现所示，完全有能力应对严重的市场下跌。</p>
</div><h2>Key Points In This Article:</h2>
<div class="lb-trans"><h2>本文要点：</h2>
</div><ul>
<li>Altria purchase of vape maker NJOY gives it access to a massive distribution network.</li>
<li>Marlboro remains a giant in the U.S. cigarette industry with 42% of the market share.</li>
<li>If you’re looking for a megatrend with massive potential, make sure to grab a complimentary copy of our “The Next NVIDIA” report. This report breaks down AI stocks with 10x potential and will give you a huge leg up on profiting from this massive sea change.</li>
</ul>
<div class="lb-trans"><ul>
<li>奥驰亚收购电子烟制造商 NJOY，使其获得了庞大的分销网络。</li>
<li>万宝路在美国香烟行业中仍占据 42% 的市场份额。</li>
<li>如果你在寻找具有巨大潜力的重大趋势，确保获取我们免费的《下一个 NVIDIA》报告。该报告详细分析了具有 10 倍潜力的人工智能股票，将为你在这一重大变革中获利提供巨大的帮助。</li>
</ul>
</div><h2>Altria’s Recent Stock Success</h2>
<div class="lb-trans"><h2>奥驰亚近期股票成功</h2>
</div><p>In 2016, Altria acquired 10% of <strong>Anheuser Busch InBev NV ADR (NYSE: BUD)</strong>, the maker of Budweiser beer. The company has since reduced its stake to 8%, but the initial investment marked a run of M&amp;A activity that increased CapEx but intrinsically increased the company’s valuation. Sherman Group Holdings, LLC was purchased in 2018, followed by Helix Innovations and Cronos Group — a medical and recreational cannabis company — being added to the Altria portfolio in 2019. In 2023, the company acquired NJOY.</p>
<div class="lb-trans"><p>2016 年，奥驰亚收购了 <strong>安海斯 - 布希英博（Anheuser Busch InBev NV ADR）</strong>（<strong>纽约证券交易所代码：BUD</strong>）10% 的股份，该公司是百威啤酒的制造商。此后，该公司将其持股比例减少至 8%，但最初的投资标志着一系列并购活动，增加了资本支出，同时内在地提高了公司的估值。2018 年收购了谢尔曼集团控股公司（Sherman Group Holdings, LLC），随后在 2019 年将海利克斯创新公司（Helix Innovations）和克罗诺斯集团（Cronos Group）——一家医疗和娱乐大麻公司——纳入奥驰亚的投资组合。2023 年，该公司收购了 NJOY。</p>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Fiscal Year</strong></td>
<td><strong>Price</strong></td>
<td><strong>Revenues</strong></td>
<td><strong>Net Income</strong></td>
</tr>
<tr>
<td>2015</td>
<td>$58.21</td>
<td>$18.854 B</td>
<td>$5.241 B</td>
</tr>
<tr>
<td>2016</td>
<td>$67.62</td>
<td>$19.337 B</td>
<td>$14.239 B</td>
</tr>
<tr>
<td>2017</td>
<td>$71.41</td>
<td>$19.494 B</td>
<td>$10.222 B</td>
</tr>
<tr>
<td>2018</td>
<td>$49.39</td>
<td>$19.627 B</td>
<td>$6.963 B</td>
</tr>
<tr>
<td>2019</td>
<td>$49.91</td>
<td>$19.796 B</td>
<td>(-$1.239 B)</td>
</tr>
<tr>
<td>2020</td>
<td>$41.00</td>
<td>$20.841 B</td>
<td>$4.467 B</td>
</tr>
<tr>
<td>2021</td>
<td>$47.39</td>
<td>$21.111 B</td>
<td>$2.475 B</td>
</tr>
<tr>
<td>2022</td>
<td>$45.71</td>
<td>$20.688 B</td>
<td>$5.764 B</td>
</tr>
<tr>
<td>2023</td>
<td>$40.34</td>
<td>$20.502 B</td>
<td>$8.130 B</td>
</tr>
<tr>
<td>2024</td>
<td>$52.38</td>
<td>$24.018 B</td>
<td>$11.236 B</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>财年</strong></td>
<td><strong>价格</strong></td>
<td><strong>收入</strong></td>
<td><strong>净收入</strong></td>
</tr>
<tr>
<td>2015</td>
<td>$58.21</td>
<td>$188.54 亿</td>
<td>$52.41 亿</td>
</tr>
<tr>
<td>2016</td>
<td>$67.62</td>
<td>$193.37 亿</td>
<td>$142.39 亿</td>
</tr>
<tr>
<td>2017</td>
<td>$71.41</td>
<td>$194.94 亿</td>
<td>$102.22 亿</td>
</tr>
<tr>
<td>2018</td>
<td>$49.39</td>
<td>$196.27 亿</td>
<td>$69.63 亿</td>
</tr>
<tr>
<td>2019</td>
<td>$49.91</td>
<td>$197.96 亿</td>
<td>(-$12.39 亿)</td>
</tr>
<tr>
<td>2020</td>
<td>$41.00</td>
<td>$208.41 亿</td>
<td>$44.67 亿</td>
</tr>
<tr>
<td>2021</td>
<td>$47.39</td>
<td>$211.11 亿</td>
<td>$24.75 亿</td>
</tr>
<tr>
<td>2022</td>
<td>$45.71</td>
<td>$206.88 亿</td>
<td>$57.64 亿</td>
</tr>
<tr>
<td>2023</td>
<td>$40.34</td>
<td>$205.02 亿</td>
<td>$81.30 亿</td>
</tr>
<tr>
<td>2024</td>
<td>$52.38</td>
<td>$240.18 亿</td>
<td>$112.36 亿</td>
</tr>
</tbody>
</table>
</div><p>From FY 2020 to FY 2024, Altria returned more than $32 billion to shareholders in the form of dividends. Over the same period, it was able to repurchase $7.9 billion worth of stock. And from August 2023 to August 2024, the company increased its dividend by more than 4.1%.</p>
<div class="lb-trans"><p>从 2020 财年到 2024 财年，奥驰亚以股息的形式向股东返还了超过 320 亿美元。在此期间，公司还回购了价值 79 亿美元的股票。从 2023 年 8 月到 2024 年 8 月，该公司将股息提高了超过 4.1%。</p>
</div><h2>Key Drivers for Altria’s Stock in the Future</h2>
<div class="lb-trans"><h2>奥驰亚未来股票的关键驱动因素</h2>
</div><p><strong>1. Growing Demand for Smokeless Products:</strong> Globally, the smokeless product industry is valued at $16.81 billion and is projected to undergo a compound annual growth rate (CAGR) of 4.8% from 2024 to 2030. While 84.9% of distribution is offline, online distribution is forecast for a 6.2% CAGR through 2030, which is likely to help bolster sales as these products continue to expand their global reach. NJOY achieved the first-ever FDA marketing granted orders for menthol e-vapor products.</p>
<div class="lb-trans"><p><strong>1. 对无烟产品的需求增长：</strong> 全球无烟产品行业的价值为 168.1 亿美元，预计在 2024 年至 2030 年期间将以 4.8% 的年复合增长率（CAGR）增长。虽然 84.9% 的分销是线下的，但预计在线分销在 2030 年前将以 6.2% 的 CAGR 增长，这可能会帮助推动销售，因为这些产品继续扩大其全球影响力。NJOY 获得了 FDA 首次批准的薄荷电子蒸汽产品的市场营销许可。</p>
</div><p><strong>2. Continuous</strong>Dividend Growth:**** Last year, Altria notched its 55th consecutive year of dividend growth. The stock continues to be a favorite among income investors, and it currently pays a dividend yielding 6.97%. For context, yield-investing fan favorite <strong>Schwab U.S. Dividend Equity ETF (NYSE: SCHD)</strong> currently only pays 4.18% and has seen a year-to-date loss of -6.97%. As such, Altria continues to provide investors with a safe haven, alluring (and sustainable) yield and impressive share performance.</p>
<div class="lb-trans"><p><strong>2. 持续的股息增长：</strong> 去年，奥驰亚实现了连续第 55 年的股息增长。该股继续受到收入投资者的青睐，目前的股息收益率为 6.97%。作为对比，收益投资者的热门选择 <strong>施瓦布美国股息股票 ETF（Schwab U.S. Dividend Equity ETF）</strong>（<strong>纽约证券交易所代码：SCHD</strong>）目前仅支付 4.18% 的股息，并且年初至今已下跌-6.97%。因此，奥驰亚继续为投资者提供安全的避风港、诱人的（且可持续的）收益和令人印象深刻的股价表现。</p>
</div><p><strong>3. Emerging Markets:</strong> Cronos (cannabinoid) and Helix (oral nicotine pouches) were both acquired in 2019 and should help Altria expand into those respective markets. This is particularly relevant in light of the FDA announcing in January 2025 that it has authorized marketing of 20 ZYN Nicotine Pouch Products — a major competitor — following an extensive scientific review.</p>
<div class="lb-trans"><p><strong>3. 新兴市场：</strong> 克罗诺斯（Cronos，含大麻成分）和海利克斯（Helix，口腔尼古丁袋）均在 2019 年被收购，应该有助于奥驰亚在这些市场的扩展。考虑到 FDA 在 2025 年 1 月宣布已授权 20 种 ZYN 尼古丁袋产品的市场营销——这是一个主要竞争对手——这一点尤其相关，经过广泛的科学审查。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://247wallst.com/wp-content/uploads/2019/01/imageforentry15-quc.jpg" alt="" original-src="https://247wallst.com/wp-content/uploads/2019/01/imageforentry15-quc.jpg"/></p>
<h2>Altria (MO) Price Prediction for 2025</h2>
<div class="lb-trans"><h2>奥驰亚（MO）2025 年价格预测</h2>
</div><p>According to Wall Street analysts, the current consensus one-year price target for Altria Group is $54.88, which represents -6.28% potential downside over the next 12 months based on the current share price. Of the nine analysts covering MO, the stock is given a consensus ‘Hold’ rating, with three assigning a ‘Buy’ rating, four assigning a ‘Hold’ rating and two assigning a ‘Sell’ rating.</p>
<div class="lb-trans"><p>根据华尔街分析师的观点，奥驰亚集团当前的一年期共识目标价为 54.88 美元，这意味着在未来 12 个月内相较于当前股价有-6.28% 的潜在下跌。在覆盖 MO 的九位分析师中，该股被给予共识 “持有” 评级，其中三位给予 “买入” 评级，四位给予 “持有” 评级，二位给予 “卖出” 评级。</p>
</div><p>However, <strong>24/7 Wall Street</strong>’s forecast is less bearish, with a projected price target for Altria Group of $56.65, or -2.20% potential downside. We believe that Altria’s high dividend and relatively low P/E ratio will continue to attract investors, which will in turn support the stock price amid the ongoing downturn in the broad market.</p>
<div class="lb-trans"><p>然而，<strong>24/7 Wall Street</strong> 的预测则不那么悲观，预计奥驰亚集团的目标价为 56.65 美元，或-2.20% 的潜在下跌。我们认为，奥驰亚的高股息和相对较低的市盈率将继续吸引投资者，从而在大盘持续下跌的情况下支撑股价。</p>
</div><h2>Altria Stock Price Target 2025–2030</h2>
<div class="lb-trans"><h2>奥驰亚股票价格目标 2025–2030</h2>
</div><p>By the conclusion of 2030, <strong>24/7 Wall Street</strong> estimates that Altria’s stock will be trading for $65.15, good for an 11.25% increase over today’s share price, based on an EPS of $6.05.</p>
<div class="lb-trans"><p>到 2030 年末，<strong>24/7 Wall Street</strong> 预计奥驰亚集团的股票将交易至 65.15 美元，相较于今天的股价上涨 11.25%，基于每股收益为 6.05 美元。</p>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Year</strong></td>
<td><strong>EPS</strong></td>
<td><strong>Price Target</strong></td>
<td><strong>% Change From Current Price</strong></td>
</tr>
<tr>
<td>2025</td>
<td>$5.32</td>
<td>$57.27</td>
<td>-2.20%</td>
</tr>
<tr>
<td>2026</td>
<td>$5.50</td>
<td>$59.24</td>
<td>1.16%</td>
</tr>
<tr>
<td>2027</td>
<td>$5.67</td>
<td>$61.06</td>
<td>4.26%</td>
</tr>
<tr>
<td>2028</td>
<td>$5.77</td>
<td>$62.10</td>
<td>6.04%</td>
</tr>
<tr>
<td>2029</td>
<td>$5.90</td>
<td>$63.55</td>
<td>8.52%</td>
</tr>
<tr>
<td>2030</td>
<td>$6.05</td>
<td>$65.15</td>
<td>11.25%</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>年份</strong></td>
<td><strong>每股收益</strong></td>
<td><strong>目标价格</strong></td>
<td><strong>与当前价格的变化百分比</strong></td>
</tr>
<tr>
<td>2025</td>
<td>$5.32</td>
<td>$57.27</td>
<td>-2.20%</td>
</tr>
<tr>
<td>2026</td>
<td>$5.50</td>
<td>$59.24</td>
<td>1.16%</td>
</tr>
<tr>
<td>2027</td>
<td>$5.67</td>
<td>$61.06</td>
<td>4.26%</td>
</tr>
<tr>
<td>2028</td>
<td>$5.77</td>
<td>$62.10</td>
<td>6.04%</td>
</tr>
<tr>
<td>2029</td>
<td>$5.90</td>
<td>$63.55</td>
<td>8.52%</td>
</tr>
<tr>
<td>2030</td>
<td>$6.05</td>
<td>$65.15</td>
<td>11.25%</td>
</tr>
</tbody>
</table>
</div><p>The post Altria Group, Inc. (NYSE: MO) Price Prediction and Forecast 2025-2030 (April 2025) appeared first on 24/7 Wall St..</p>
<div class="lb-trans"><p>关于奥驰亚集团（NYSE: MO）的价格预测与 2025-2030 年展望（2025 年 4 月）首次发布于 24/7 Wall St..</p>
</div>

奥驰亚集团公司（NYSE: MO）2025-2030 年价格预测和展望（2025 年 4 月）